NASDAQ:UTHR

United Therapeutics Stock News

etoro logo Buy UTHR
*Your capital is at risk
$549.47
+9.42 (+1.74%)
At Close: Jun 03, 2026

3 Biotech Stocks to Buy Now: Q3 Edition

09:04pm, Monday, 15'th Jul 2024
Biotech stocks to buy can be an interesting sector for investors. They can provide massive gains following positive news regarding clinical trials or FDA approvals.
United Therapeutics (UTHR) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Does United Therapeutics (UTHR) have what it takes to be a top stock pick for momentum investors? Let's find out.
Investors with an interest in Medical - Drugs stocks have likely encountered both United Therapeutics (UTHR) and Catalent (CTLT). But which of these two companies is the best option for those looking
United Therapeutics (UTHR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
United Therapeutics' (UTHR) late-stage study is evaluating Tyvaso inhalation solution in IPF patients living outside the United States and Canada.
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
United Therapeutics (UTHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Identifying undervalued growth stocks to buy presents a compelling opportunity for savvy investors. Often overlooked or misunderstood by the broader market, these companies can potentially deliver out
Every investment category must answer the big question, why? For undervalued biotech stocks, it comes down to advantaging a supremely relevant sector without paying full price.

Big Money Elevating United Therapeutics

10:36am, Friday, 28'th Jun 2024
The medical devices and novel treatments United Therapeutics Corporation (UTHR) develops to treat pulmonary arterial hypertension (PAH) and other ailments are attracting substantial Big Money investme
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Medical devices are spearheading the digitalization of healthcare, reports analytics and software development company Luxoft. Specifically, medical devices are “providing accurate diagnoses, effecti
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE